Sight Sciences, Inc.
SGHT
$2.69
-$0.10-3.58%
| Weiss Ratings | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.94 | |||
| Price History | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.17% | |||
| 30-Day Total Return | -14.06% | |||
| 60-Day Total Return | -31.03% | |||
| 90-Day Total Return | -48.96% | |||
| Year to Date Total Return | -24.86% | |||
| 1-Year Total Return | -38.44% | |||
| 2-Year Total Return | -71.38% | |||
| 3-Year Total Return | -79.70% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -66.98% | |||
| 52-Week Low % Change | 28.57% | |||
| Price | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.45 | |||
| 52-Week Low Price | $2.17 | |||
| 52-Week Low Price (Date) | Mar 06, 2025 | |||
| 52-Week High Price (Date) | Jul 23, 2024 | |||
| Valuation | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 143.22M | |||
| Enterprise Value | 63.22M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.03 | |||
| Earnings Per Share Growth | -9.99% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.77 | |||
| Price/Book (Q) | 1.62 | |||
| Enterprise Value/Revenue (TTM) | 0.79 | |||
| Price | $2.69 | |||
| Enterprise Value/EBITDA (TTM) | -1.27 | |||
| Enterprise Value/EBIT | -1.25 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 50.80M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 266 1144 | |||
| Address | 4040 Campbell Avenue Menlo Park, CA 94025 | |||
| Website | www.sightsciences.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -63.27% | |||
| Profit Margin | -64.49% | |||
| Management Effectiveness | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.41% | |||
| Return on Equity | -- | |||
| Income Statement | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 79.87M | |||
| Total Revenue (TTM) | 79.87M | |||
| Revenue Per Share | $1.57 | |||
| Gross Profit (TTM) | 68.29M | |||
| EBITDA (TTM) | -49.82M | |||
| EBIT (TTM) | -50.53M | |||
| Net Income (TTM) | -51.51M | |||
| Net Income Avl. to Common (TTM) | -51.51M | |||
| Total Revenue Growth (Q YOY) | 1.72% | |||
| Earnings Growth (Q YOY) | -10.80% | |||
| EPS Diluted (TTM) | -1.03 | |||
| EPS Diluted Growth (Q YOY) | -6.68% | |||
| Balance Sheet | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 120.36M | |||
| Cash Per Share (Q) | $2.37 | |||
| Total Current Assets (Q) | 139.77M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 87.52M | |||
| Current Ratio (Q) | 9.036 | |||
| Book Value Per Share (Q) | $1.72 | |||
| Total Assets (Q) | 142.84M | |||
| Total Current Liabilities (Q) | 15.47M | |||
| Total Debt (Q) | 40.36M | |||
| Total Liabilities (Q) | 55.32M | |||
| Total Common Equity (Q) | 87.52M | |||
| Cash Flow | SGHT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -385.00K | |||
| Cash from Financing (TTM) | 4.96M | |||
| Net Change in Cash (TTM) | -17.77M | |||
| Levered Free Cash Flow (TTM) | -5.54M | |||
| Cash from Operations (TTM) | -22.35M | |||
